Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Pulmonary Hypertension

  Free Subscription


15.09.2025

1 Am J Physiol Heart Circ Physiol
1 Am J Prev Cardiol
1 Am J Respir Crit Care Med
1 Ann Am Thorac Soc
1 Ann Hematol
1 Ann Rheum Dis
1 Basic Clin Pharmacol Toxicol
1 Cardiol Rev
1 Cardiol Young
1 Cardiovasc Hematol Agents Med Chem
1 Chem Biol Interact
1 Chest
1 Clin Res Cardiol
1 Curr Drug Metab
1 Eur J Radiol
1 Front Med (Lausanne)
1 Front Pediatr
1 Heart Fail Rev
1 Int J Cardiol
1 J Chin Med Assoc
1 J Clin Hypertens (Greenwich)
1 Monaldi Arch Chest Dis
1 Nucl Med Commun
1 Open Heart
1 Physiol Rep
1 PLoS One
1 Respir Med
2 Vascul Pharmacol
1 Zhonghua Jie He He Hu Xi Za Zhi


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Physiol Heart Circ Physiol

  1. LECHUGA CG, Raza F, Colebank MJ, Korcarz CE, et al
    Wave intensity analysis with exercise identifies impairments in pulmonary hypertension.
    Am J Physiol Heart Circ Physiol. 2025 Sep 12. doi: 10.1152/ajpheart.00194.2025.
    PubMed         Abstract available


    Am J Prev Cardiol

  2. MAJMUNDAR M, Patel KN, Khawaja T, Doshi R, et al
    Impact of mode of delivery on maternal and fetal outcomes in pregnant patients with heart failure or pulmonary hypertension.
    Am J Prev Cardiol. 2025;23:101263.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  3. SHLOBIN OA, Piccari L
    A 10,000-Foot View at Survival and Treatment with PDE5 Inhibitors in Interstitial Lung Disease Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2025 Sep 8. doi: 10.1164/rccm.202508-1980.
    PubMed        


    Ann Am Thorac Soc

  4. VAHDATPOUR C, Virk S, Ding H, Epstein S, et al
    Morning Larks and Night Owls: Considering Chronotype in Evaluation of Patients with Pulmonary Hypertension.
    Ann Am Thorac Soc. 2025 Sep 10. doi: 10.1513/AnnalsATS.202502.
    PubMed         Abstract available


    Ann Hematol

  5. BIRSIN Z, Salihoglu A, Tokdil KO, Pirdal BZ, et al
    Is splenectomy one of the contributory factors to pulmonary hypertension? An analysis of splenectomized hemolytic anemia and immune thrombocytopenia patients.
    Ann Hematol. 2025 Sep 9. doi: 10.1007/s00277-025-06583.
    PubMed         Abstract available


    Ann Rheum Dis

  6. BOUCLY A, Mitrovic S, Carmagnat M, Savale L, et al
    Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15.
    Ann Rheum Dis. 2025;84:1538-1548.
    PubMed         Abstract available


    Basic Clin Pharmacol Toxicol

  7. LELKOVA K, Hadova K, Katanova M, Babiakova J, et al
    Pleural Effusion Formation Linked to Altered Transporter Expression Involved in Alveolar Fluid Clearance: Insights From the Monocrotaline Model of Pulmonary Hypertension.
    Basic Clin Pharmacol Toxicol. 2025;137:e70096.
    PubMed         Abstract available


    Cardiol Rev

  8. ELATTAR S, Basha NR, Salem A, Abdulfattah AY, et al
    Tadalafil for Treatment of Pulmonary Hypertension: Mechanisms, Evidence, and Emerging Perspectives.
    Cardiol Rev. 2025 Sep 12. doi: 10.1097/CRD.0000000000001036.
    PubMed         Abstract available


    Cardiol Young

  9. SANTOS IA, Graca IS, Placido R, Nogueira G, et al
    Kartagener's syndrome with congenital heart defect-an old rare disease with a new rare face.
    Cardiol Young. 2025;35:1734-1739.
    PubMed         Abstract available


    Cardiovasc Hematol Agents Med Chem

  10. DENG F, Sun J, Liu L, Zhang M, et al
    The Predictive Value of Monocyte-to-HDL Cholesterol Ratio in Patients with Dilated Cardiomyopathy and Associated Pulmonary Hypertension.
    Cardiovasc Hematol Agents Med Chem. 2025.
    PubMed         Abstract available


    Chem Biol Interact

  11. ZHANG C, Song Z, Zhao Y, Guo X, et al
    The underexplored pulmonary toxicity of pyrrolizidine alkaloids: Emerging hazard from food contamination.
    Chem Biol Interact. 2025;420:111709.
    PubMed         Abstract available


    Chest

  12. JOSE A, Sood N, Elwing JM, Akkanti B, et al
    "How I Do It": Pulmonary Hypertension Associated with Interstitial Lung Diseases.
    Chest. 2025 Sep 10:S0012-3692(25)05167-0. doi: 10.1016/j.chest.2025.07.4107.
    PubMed         Abstract available


    Clin Res Cardiol

  13. HUDEC M, Januska J, Jiravsky O, Miklik R, et al
    Impact of pulmonary hypertension dynamics and residual mitral regurgitation shortly after M-TEER on long-term outcomes: insights from a prospective registry.
    Clin Res Cardiol. 2025 Sep 8. doi: 10.1007/s00392-025-02747.
    PubMed         Abstract available


    Curr Drug Metab

  14. GONG X, Min F, Guo J, Zhang Z, et al
    Mechanism of Tetrandrine in Ameliorating Hypoxic Pulmonary Hypertension Vascular Remodeling through Transcriptomics and Metabolomics.
    Curr Drug Metab. 2025 Sep 3. doi: 10.2174/0113892002393801250812063417.
    PubMed         Abstract available


    Eur J Radiol

  15. SYNN AJ, Nardelli P, Renapurkar R, Quesada L, et al
    Spatial heterogeneity and distribution of CT-Based pulmonary vascular volumes in chronic thromboembolic pulmonary hypertension.
    Eur J Radiol. 2025;192:112405.
    PubMed         Abstract available


    Front Med (Lausanne)

  16. ZHANG X, Peng M, Ren R, Li W, et al
    Pulmonary hypertension secondary to Abernethy malformation with left inferior vena cava: a case report and literature review.
    Front Med (Lausanne). 2025;12:1604853.
    PubMed         Abstract available


    Front Pediatr

  17. WANG S, Yang P, Xi H, Yin X, et al
    Case Report: Shared manifestation, distinct etiologies: severe pulmonary hypertension in both mother and neonate.
    Front Pediatr. 2025;13:1612410.
    PubMed         Abstract available


    Heart Fail Rev

  18. CAO JJL, Reddy YNV
    Evaluation of pulmonary hypertension in heart failure with preserved ejection fraction.
    Heart Fail Rev. 2025 Sep 9. doi: 10.1007/s10741-025-10553.
    PubMed         Abstract available


    Int J Cardiol

  19. HINOJOSA W, Velazquez-Martin M, Coronel ML, Segura de la Cal T, et al
    Prognostic value of longitudinal QTc interval analysis in pulmonary arterial hypertension.
    Int J Cardiol. 2025;441:133816.
    PubMed         Abstract available


    J Chin Med Assoc

  20. CHIOU FR, Sung SH, Chiu JH, Guo CY, et al
    Cardiac magnetic resonance parameters for prognostic stratification in pulmonary hypertension: A longitudinal study.
    J Chin Med Assoc. 2025 Sep 10. doi: 10.1097/JCMA.0000000000001292.
    PubMed         Abstract available


    J Clin Hypertens (Greenwich)

  21. GU W, Li L, Ahmad A, Lv J, et al
    A Machine Learning-Based Model to Estimate the Risk of Pulmonary Hypertension in Chronic Kidney Disease Patients.
    J Clin Hypertens (Greenwich). 2025;27:e70132.
    PubMed         Abstract available


    Monaldi Arch Chest Dis

  22. ERTAN HARPUTLU O, Kuran Aslan G, Akinci B, Bilge AK, et al
    Investigation of different field tests in relation to balance, daily living activities, and quality of life in pulmonary hypertension.
    Monaldi Arch Chest Dis. 2025 Sep 8. doi: 10.4081/monaldi.2025.3308.
    PubMed         Abstract available


    Nucl Med Commun

  23. PENCHARZ D, Pliszka R, Peters AM
    The effect of Tc-99m-macroaggregated albumin administration on pulmonary vascular resistance.
    Nucl Med Commun. 2025;46:1013-1017.
    PubMed         Abstract available


    Open Heart

  24. RAVINDRAN JV, Chung T, Naoum C, Yiannikas J, et al
    Prominent V waves in right heart catheterisation as a marker of left atrial stiffness in pulmonary hypertension.
    Open Heart. 2025;12:e003399.
    PubMed         Abstract available


    Physiol Rep

  25. BERGSTROM E, Pola K, Kjellstrom B, Toger J, et al
    Increased contractility affects left ventricular kinetic energy in pulmonary hypertension.
    Physiol Rep. 2025;13:e70563.
    PubMed         Abstract available


    PLoS One

  26. CHEN R, Guo D, Pan J, Pang L, et al
    Comprehensive analysis of disulfidptosis-related genes in pulmonary hypertension through machine learning and immune infiltration: Spotlight on USP32 and ZNF655 as key regulators.
    PLoS One. 2025;20:e0330832.
    PubMed         Abstract available


    Respir Med

  27. BRAND J, de Graaf W, Geiser T, Martinelli M, et al
    Frailty in pulmonary hypertension: Establishing the frailty index and impact on survival.
    Respir Med. 2025;248:108346.
    PubMed         Abstract available


    Vascul Pharmacol

  28. GIULIANI L, D'Alto M, Di Poi E, Dagna L, et al
    Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study.
    Vascul Pharmacol. 2025;160:107529.
    PubMed         Abstract available

  29. ABDULELAH M, Ezenna C, Jenil-Franco A, Jamouss KT, et al
    Clinical outcomes and safety of sotatercept in pulmonary arterial hypertension: A systematic review and meta-analysis of randomized controlled trials.
    Vascul Pharmacol. 2025;160:107520.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi

  30. LIN H, Sun F, Wang L, Gong SG, et al
    [Anti-EJ antibody positive antisynthetase syndrome with pulmonary hypertention:a case report].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:853-855.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.